Illumina Adds IBM Watson To DNA Test For Cancer Patients
Your cancer, your treatment
Once you and your doctor determine that Watson Genomics from Quest Diagnostics® is the right approach for your cancer, a tissue sample from your tumor will be sent to Quest to undergo gene sequencing to determine which genetic alterations it may have. Quest then uploads the sequenced genetic file to Watson for Genomics to provide them with information to help them identify mutations in your cancer that are potentially treatable, and these insights could then help your doctor identify targeted treatments for you.
Information to help enhance confidence
In addition to providing information regarding your tumor’s genetic alterations, Watson for Genomics also draws evidence from a vast corpus of medical literature, as well as MSK’s OncoKB, a precision oncology knowledge base. A comparison that may typically take a team of medical experts weeks to prepare can now be completed in significantly less time. This can help clinicians and their patients and cancer care teams feel more confident about the path forward with an evidence-based, individualized care plan.
Information regarding actionable therapeutic options
Quest Diagnostics sequences and analyzes your patients’ tumors’ genomic makeup to help you understand the unique cancer-causing mutations specific to each individual’s sample. The test identifies base pair substitutions, insertions and deletions, copy number variations and select translocations through full-gene sequencing of 50 genes that have been determined to yield the most currently actionable mutations. A Quest Diagnostics medical director will review and validate the results and prepare a report that delivers information to the treating clinician regarding potential personalized, targeted therapeutic options.
Information to help enhance clinical confidence
In addition to providing information regarding your patients’ tumors’ genetic alterations, Watson Genomics from Quest Diagnostics® also provides supporting evidence from a vast corpus of relevant medical literature, as well as MSK’s OncoKB, a precision oncology knowledge base. A comparison that could take an oncology board weeks to prepare can now be completed in significantly less time.
Broader data for a more personalized approach
By leveraging the cognitive power of Watson for Genomics to help analyze both structured and unstructured data and information, Watson for Genomics can help compare these informational sources as they relate to your patients’ unique situations to provide a comprehensive, personalized approach.
IBM Watson for Clinical Trial Matching
Watson for Clinical Trial Matching eliminates the need to manually compare enrollment criteria with patient medical data, making it possible to efficiently screen cancer patients and identify their potential trial options with one simple solution.
IBM Watson for Oncology
Watson for Oncology helps physicians quickly make sense of their patient’s longitudinal health record, surface relevant articles, and explore treatment options to reduce the variability of care and give time back to their patients.